{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:38:10Z","timestamp":1715819890258},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,15]]},"DOI":"10.7759\/cureus.60361","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T18:04:12Z","timestamp":1715796252000},"source":"Crossref","is-referenced-by-count":0,"title":["Oncocytic Hyperplastic Nodule Versus Oncocytic Adenoma: Diagnostic Controversies Through a Brief Investigative Case Series Study"],"prefix":"10.7759","author":[{"given":"Christos","family":"Topalidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Triantafyllia","family":"Koletsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.008474","article-title":"My approach to oncocytic tumours of the thyroid","volume":"57","author":"Asa SL","year":"2004","unstructured":"Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol. 2004, 57:225-32. 10.1136\/jcp.2003.008474","journal-title":"J Clin Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.55418\/9781933477329-10","article-title":"Tumors of the Thyroid and Parathyroid Glands","author":"Rosai J","year":"2014","unstructured":"Rosai J, DeLellis RA, Carcangin ML, Frable WJ, Tallini G. Tumors of the Thyroid and Parathyroid Glands. ARP PRESS, Maryland; 2014. 10.55418\/9781933477329-10"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch ZW","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, et al.. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022, 33:27-63. 10.1007\/s12022-022-09707-3","journal-title":"Endocr Pathol"},{"key":"ref4","article-title":"Endocrine and Neuroendocrine Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board. Endocrine and Neuroendocrine Tumours. International Agency for Research on Cancer, Lyon; 2022."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.678119","article-title":"Oncocytic change in thyroid pathology","volume":"12","author":"Asa SL","year":"2021","unstructured":"Asa SL, Mete O. Oncocytic change in thyroid pathology. Front Endocrinol (Lausanne). 2021, 12:678119. 10.3389\/fendo.2021.678119","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22101","article-title":"The prevalence and surgical outcomes of H\u00fcrthle cell lesions in FNAs of the thyroid: a multi-institutional study in 6 Asian countries","volume":"127","author":"Agarwal S","year":"2019","unstructured":"Agarwal S, Bychkov A, Jung CK, et al.. The prevalence and surgical outcomes of H\u00fcrthle cell lesions in FNAs of the thyroid: a multi-institutional study in 6 Asian countries. Cancer Cytopathol. 2019, 127:181-91. 10.1002\/cncy.22101","journal-title":"Cancer Cytopathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-13-0051","article-title":"Late bone metastasis from an apparently benign oncocytic follicular thyroid tumor","volume":"2013","author":"Boronat M","year":"2013","unstructured":"Boronat M, Cabrera JJ, Perera C, Isla C, N\u00f3voa FJ. Late bone metastasis from an apparently benign oncocytic follicular thyroid tumor. Endocrinol Diabetes Metab Case Rep. 2013, 2013:130051. 10.1530\/EDM-13-0051","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0052","article-title":"Be aware of the patient with benign follicular thyroid lesion histology and rising thyroglobulin level","volume":"24","author":"Slutzky-Shraga I","year":"2018","unstructured":"Slutzky-Shraga I, Sternov Y, Robenshtock E, Tzvetov G, Benbassat C, Hirsch D. Be aware of the patient with benign follicular thyroid lesion histology and rising thyroglobulin level. Endocr Pract. 2018, 24:740-5. 10.4158\/EP-2018-0052","journal-title":"Endocr Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3539","article-title":"Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy","volume":"98","author":"Ganly I","year":"2013","unstructured":"Ganly I, Ricarte Filho J, Eng S, et al.. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab. 2013, 98:E962-72. 10.1210\/jc.2012-3539","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-018-0546-x","article-title":"Approach the invasive potential with Hurthle cell tumors of thyroid","volume":"25","author":"Ding L","year":"2019","unstructured":"Ding L, Jiang Y, Yang W. Approach the invasive potential with Hurthle cell tumors of thyroid. Pathol Oncol Res. 2019, 25:697-701. 10.1007\/s12253-018-0546-x","journal-title":"Pathol Oncol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12737","article-title":"The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives","volume":"68","author":"Kakudo K","year":"2018","unstructured":"Kakudo K, Bychkov A, Bai Y, Li Y, Liu Z, Jung CK. The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives. Pathol Int. 2018, 68:641-64. 10.1111\/pin.12737","journal-title":"Pathol Int"},{"key":"ref12","unstructured":"Follicular adenoma. (2023). Accessed. December 16, 2023: https:\/\/www.pathologyoutlines.com\/topic\/thyroidfollicularadenoma.html."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010026","article-title":"Thyroid H\u00fcrthle cell carcinoma: clinical, pathological, and molecular features","volume":"13","author":"Kure S","year":"2020","unstructured":"Kure S, Ohashi R. Thyroid H\u00fcrthle cell carcinoma: clinical, pathological, and molecular features. Cancers (Basel). 2020, 13:26. 10.3390\/cancers13010026","journal-title":"Cancers (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/dc.24247","article-title":"H\u00fcrthle cell lesions on thyroid fine needle aspiration cytology: molecular and histologic correlation","volume":"47","author":"Schatz-Siemers N","year":"2019","unstructured":"Schatz-Siemers N, Brandler TC, Oweity T, Sun W, Hernandez A, Levine P. H\u00fcrthle cell lesions on thyroid fine needle aspiration cytology: molecular and histologic correlation. Diagn Cytopathol. 2019, 47:977-85. 10.1002\/dc.24247","journal-title":"Diagn Cytopathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2004.05.061","article-title":"Molecular analysis of Hurthle cell neoplasms by gene profiling","volume":"136","author":"Finley DJ","year":"2004","unstructured":"Finley DJ, Zhu B, Fahey TJ 3rd. Molecular analysis of Hurthle cell neoplasms by gene profiling. Surgery. 2004, 136:1160-8. 10.1016\/j.surg.2004.05.061","journal-title":"Surgery"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061325","article-title":"New insights in thyroid cancer and p53 family proteins","volume":"18","author":"Manzella L","year":"2017","unstructured":"Manzella L, Stella S, Pennisi MS, et al.. New insights in thyroid cancer and p53 family proteins. Int J Mol Sci. 2017, 18:1325. 10.3390\/ijms18061325","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-21-0095","article-title":"Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma?","volume":"28","author":"Nikitski AV","year":"2021","unstructured":"Nikitski AV, Nikiforova MN, Yip L, Karslioglu-French E, Carty SE, Nikiforov YE. Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma?. Endocr Relat Cancer. 2021, 28:621-30. 10.1530\/ERC-21-0095","journal-title":"Endocr Relat Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/241716-oncocytic-hyperplastic-nodule-versus-oncocytic-adenoma-diagnostic-controversies-through-a-brief-investigative-case-series-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T18:04:16Z","timestamp":1715796256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/241716-oncocytic-hyperplastic-nodule-versus-oncocytic-adenoma-diagnostic-controversies-through-a-brief-investigative-case-series-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.60361","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,15]]}}}